Role of global longitudinal strain in discriminating variant forms of left ventricular hypertrophy and predicting mortality.


Journal

Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 18 12 2021
Statut: ppublish

Résumé

In this study, we aimed to compare the functional adaptations of the left ventricle in variant forms of left ventricular hypertrophy (LVH) and to evaluate the use of two-dimensional speckle tracking echocardiography (2D-STE) in differential diagnosis and prognosis. This was a prospective cohort study of 68 patients with LVH, including 20 patients with non-obstructive hypertrophic cardiomyopathy (HCM), 23 competitive top-level athletes free of cardiovascular disease, and 25 patients with hypertensive heart disease (HHD). All the subjects underwent 2D transthoracic echocardiography (TTE) and 2D-STE. The primary endpoint was all-cause mortality. Global longitudinal strain (GLS) below -12.5% was defined as severely reduced strain, -12.5% to -17.9% as mildly reduced strain, and above -18% as normal strain. The mean LV-GLS value was higher in athletes than in patients with HCM and HHD with the lowest value being in the HCM group (HCM: -11.4±2.2%; HHD: -13.6±2.6%; and athletes: -15.5±2.1%; p<0.001 among groups). LV-GLS below -12.5% distinguished HCM from others with 65% sensitivity and 77% specificity [area under curve (AUC)=0.808, 95% confidence interval (CI): 0.699-0.917, p<0.001]. The median follow-up duration was 6.4±1.1 years. Overall, 11 patients (16%) died. Seven of these were in the HHD group, and four were in the HCM group. The mean GLS value in patients who died was -11.8±1.5%. LV-GLS was significantly associated with mortality after adjusting age and sex via multiple analysis (RR=0.723, 95% CI: 0.537-0.974, p=0.033). Patients with GLS below -12.5% had a higher risk of all-cause mortality compared with that of patients with GLS above -12.5% according to Kaplan-Meier survival analysis for 7 years (29% vs. 9%; p=0.032). The LV-GLS value predicts mortality with 64% sensitivity and 70% specificity with a cut-off value of -12.5 (AUC=0.740, 95% CI: 0.617-0.863, p=0.012). The 2D-STE provides important information about the longitudinal systolic function of the myocardium. It may enable differentiation variable forms of LVH and predict prognosis.

Identifiants

pubmed: 34866580
doi: 10.5152/AnatolJCardiol.2021.21940
pmc: PMC8654011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

863-871

Références

J Am Coll Cardiol. 1995 Mar 15;25(4):871-8
pubmed: 7884090
Circulation. 2013 Jul 23;128(4):388-400
pubmed: 23877061
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):260-274
pubmed: 29413646
Ann Intern Med. 1969 Jul;71(1):89-105
pubmed: 4239887
J Am Coll Cardiol. 1986 Jan;7(1):190-203
pubmed: 2934463
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
J Am Coll Cardiol. 2018 May 8;71(18):1947-1957
pubmed: 29724346
Eur Heart J Cardiovasc Imaging. 2012 Jul;13(7):617-23
pubmed: 22271116
BMJ Open. 2012 Aug 17;2(4):
pubmed: 22904333
J Am Coll Cardiol. 2008 Dec 9;52(24):1981-9
pubmed: 19055989
Int J Cardiovasc Imaging. 2011 Jan;27(1):91-100
pubmed: 20623194
N Engl J Med. 1991 Jan 31;324(5):295-301
pubmed: 1824720
Am J Med Sci. 1999 Mar;317(3):168-75
pubmed: 10100690
Eur J Echocardiogr. 2009 May;10(3):350-6
pubmed: 19246500
Cardiology. 1992;81(4-5):291-8
pubmed: 1301257
Future Cardiol. 2009 Sep;5(5):495-502
pubmed: 19715413
Circulation. 1999 Jan 19;99(2):254-61
pubmed: 9892592
Heart. 2010 May;96(9):716-22
pubmed: 20424157
Eur J Echocardiogr. 2011 Mar;12(3):167-205
pubmed: 21385887
Circulation. 2009 Mar 3;119(8):1085-92
pubmed: 19221222
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
J Am Soc Echocardiogr. 2010 Nov;23(11):1190-8
pubmed: 20810245
Am J Cardiol. 2014 Nov 1;114(9):1383-9
pubmed: 25217454
J Am Soc Echocardiogr. 2007 Feb;20(2):151-7
pubmed: 17275700
Circulation. 2000 Jul 25;102(4):470-9
pubmed: 10908222
J Am Soc Echocardiogr. 2013 Feb;26(2):185-91
pubmed: 23218891
J Am Soc Echocardiogr. 2010 Oct;23(10):1019-24
pubmed: 20810243
Circulation. 2011 Jan 25;123(3):327-34
pubmed: 21263005
Pan Afr Med J. 2016 Nov 16;25:171
pubmed: 28292133
Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):342-8
pubmed: 20560167
JAMA. 2002 Mar 13;287(10):1308-20
pubmed: 11886323
Am J Cardiol. 2003 Apr 15;91(8):1021-3, A8
pubmed: 12686356
Circulation. 2000 Oct 10;102(15):1788-94
pubmed: 11023933
J Am Soc Echocardiogr. 2015 Feb;28(2):245-53
pubmed: 25455545
Hypertension. 2014 Mar;63(3):500-6
pubmed: 24396022
Am J Cardiol. 2007 Jul 1;100(1):128-32
pubmed: 17599454
Am J Cardiol. 2001 Jul 1;88(1):53-8
pubmed: 11423058
J Am Coll Cardiol. 1997 Mar 1;29(3):641-7
pubmed: 9060905
J Clin Invest. 1999 May 15;103(10):1459-67
pubmed: 10330428

Auteurs

Pelin Karaca Özer (P)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Elif Ayduk Gövdeli (E)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Berat Engin (B)

Department of Cardiology, Manavgat State Hospital; Antalya-Turkey.

Adem Atıcı (A)

Department of Cardiology, İstanbul Medeniyet University, Göztepe Training and Research Hospital; İstanbul-Turkey.

Derya Baykız (D)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Hüseyin Orta (H)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Zeynep Gizem Demirtakan (ZG)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Samim Emet (S)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Ali Elitok (A)

Department of Cardiology, İstinye University, Liv Hospital; İstanbul-Turkey.

Yelda Tayyareci (Y)

Department of Cardiology, İstinye University, Liv Hospital; İstanbul-Turkey.

Berrin Umman (B)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Ahmet Kaya Bilge (AK)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Zehra Buğra (Z)

Department of Cardiology, İstanbul Medical Faculty, İstanbul University; İstanbul-Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH